Trends Pharmacol Sci. 2009 Dec;30(12):624-30.

Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.

Source

Genentech, Incorporated, 1 DNA Way, South San Francisco, CA 94080, USA.

Abstract

Identification and characterization of VEGF as an important regulator of angiogenesis, and FDA approval of the first anti-angiogenic drugs, has enabled significant advances in the therapy of cancer and neovascular age-related macular degeneration. However, similar to other therapies, inherent/acquired resistance to anti-angiogenic drugs may occur in patients, leading to disease recurrence. Recent studies in several experimental models suggest that tumor and non-tumor (stromal) cell types may be involved in the reduced responsiveness to the treatments. The present review examines the role of tumor- as well as stromal cell-derived pathways involved in tumor growth and in refractoriness to anti-VEGF therapies.

PMID:: 19836845; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. [Drug Resist Updat. 2008]
Review Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F, Ferrara N. Drug Resist Updat. 2008 Dec; 11(6):219-30. Epub 2008 Oct 23.
Review Pathways mediating VEGF-independent tumor angiogenesis. [Cytokine Growth Factor Rev. 2010]
Review Pathways mediating VEGF-independent tumor angiogenesis.
Ferrara N. Cytokine Growth Factor Rev. 2010 Feb; 21(1):21-6. Epub 2009 Dec 11.
Review Targeting inflammatory cells to improve anti-VEGF therapies in oncology. [Recent Results Cancer Res. 2010]
Review Targeting inflammatory cells to improve anti-VEGF therapies in oncology.
Gerber HP, Olazoglu E, Grewal IS. Recent Results Cancer Res. 2010; 180:185-200.
Review Antiangiogenesis to treat cancer and intraocular neovascular disorders. [Lab Invest. 2007]
Review Antiangiogenesis to treat cancer and intraocular neovascular disorders.
Shojaei F, Ferrara N. Lab Invest. 2007 Mar; 87(3):227-30. Epub 2007 Jan 29.
Review Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis. [Curr Opin Hematol. 2010]
Review Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
Ferrara N. Curr Opin Hematol. 2010 May; 17(3):219-24.

See reviews... See all...

Cited by 6 PubMed Central articles

Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma. [J Clin Invest. 2011]
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma.
Cascone T, Herynk MH, Xu L, Du Z, Kadara H, Nilsson MB, Oborn CJ, Park YY, Erez B, Jacoby JJ, et al. J Clin Invest. 2011 Apr; 121(4):1313-28. Epub 2011 Mar 23.
The adaptive stroma joining the antiangiogenic resistance front. [J Clin Invest. 2011]
The adaptive stroma joining the antiangiogenic resistance front.
Casanovas O. J Clin Invest. 2011 Apr; 121(4):1244-7. Epub 2011 Mar 23.
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. [Proc Natl Acad Sci U S A. 2010]
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy.
de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, et al. Proc Natl Acad Sci U S A. 2010 Aug 10; 107(32):14484-9. Epub 2010 Jul 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogeni...
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.
Trends Pharmacol Sci. 2009 Dec ;30(12):624-30.

PubMed
Post-traumatic stress disorder following traumatic injuries in adults.
Post-traumatic stress disorder following traumatic injuries in adults.
WMJ. 2004 ;103(6):69-72.

PubMed
Mortality in Dutch hospitals: trends in time, place and cause of death after adm...
Mortality in Dutch hospitals: trends in time, place and cause of death after admission for myocardial infarction and stroke. An observational study.
BMC Health Serv Res. 2008 Mar 4 ;8:52.

PubMed
Occupational radiation doses to operators performing cardiac catheterization pro...
Occupational radiation doses to operators performing cardiac catheterization procedures.
Health Phys. 2008 Mar ;94(3):211-27.

PubMed
Seroepidemiology of hepatitis A in patients with chronic liver disease.
Seroepidemiology of hepatitis A in patients with chronic liver disease.
J Viral Hepat. 2005 Jan ;12(1):101-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: